NASDAQ:RIGL
Rigel Pharmaceuticals, Inc.
- Stock
locale
United Statesmarket
STOCKSindustry
Biotechnologywebsite
www.rigel.comipo date
Nov 29, 2000
Rigel Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs to treat hematologic disorders, cancer, and rare immune diseases. The company offers Tavalisse, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia. It also develops Fostamatinib that is in phase III clinical trial for t...Show More
Earnings
Earnings Release in 4 daysEarnings per Share (Estimate*)
Revenue (Estimate*)
*Estimate based on analyst consensus